Topiramate Capsule, Coated Pellets
Product Images NDC 65841-651

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 65841-651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 04

Label for Topiramate Capsules, USP 15 mg, coated pellets oral capsules. The package contains 60 capsules. Manufacturer information includes Zydus Pharmaceuticals and Cadila Healthcare Ltd., Ahmedabad, India. The label includes storage instructions and a barcode.*

FDA Label Image

Eba681d9 6520 4797 B4c5 Bde4e86dbc20 05

Topiramate Capsules, USP 25 mg oral coated pellets in capsule form. The label displays the product name, strength, and quantity of 60 capsules. It includes storage instructions, a pharmacist dispensing warning, and manufacturing information by Zydus Lifesciences Limited and Cadila Healthcare Ltd., Ahmedabad, India. The NDC number 65841-652-14 is shown on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.